Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Falciparum Malaria
Reports from S. Garg and co-researchers add new data to research in falciparum malaria
March 26th, 2008
According to recent research published in the Malaria Journal, "The Plasmodium falciparum apical membrane antigen I (AMAI) is a leading malaria vaccine candidate antigen. The complete AMAI protein is comprised of three domains where domain I exhibits high sequence polymorphism and is thus named as the hyper-variable region (HVR)." "The present study describes the extent of genetic polymorphism and natural selection at domain I of the amal gene among Indian P. falciparum isolates. The part of the AMAI gene covering domain I was PCR amplified and sequenced from 157 P. falciparum isolates collected from five different geographical regions of India. Statistical and...
Source: Vaccine Weekly (2008-03-26)
|
